"The funding provided by ODAT and the data generated in the proof-of-concept studies were important factors in the due diligence process of obtaining equity financing," said Sandra Wells, PhD, ODAT Assistant Director. "It’s great to see one of our funded projects reaching this important milestone."

CTSI’s Translational Grant Program helps drive research that translates basic science discoveries into patient benefit, with the overarching goal of improving human health. In addition to funds, awarded projects also receive a project development team with the appropriate expertise to help determine project milestones, identify key gaps, and strengthen the project’s likelihood of advancing toward new therapeutics, diagnostics, devices, or treatment approaches.